GPT-5 Pro proposes the hypothesis that cracked a 3-year-old T-cell puzzle
OpenAI published an account of immunologist Derya Unutmaz, of The Jackson Laboratory for Genomic Medicine, feeding GPT-5 Pro a dataset his lab had been stuck on since 2022 — and getting a working answer. The model surfaced patterns in T-cell gene expression that conventional analysis had missed and proposed a hypothesis consistent with decades of prior work: that deoxyglucose removes a barrier, letting T cells more readily become Th17 cells, which explained the anomaly. The lab still validated the idea experimentally, but the AI generated the key insight, with possible bearing on cancer and autoimmune disease.
Why it matters: The meaningful line here is between summarizing what's known and proposing something new, and this account lands on the latter — a genuine hypothesis on a real, stalled problem. For researchers, the interesting shift isn't answers but generation: an LLM that can read a messy dataset and suggest a mechanism worth testing changes where a model sits in the scientific workflow, from literature-search assistant to hypothesis-generating collaborator. The load-bearing caveat is that the lab still had to validate it in the wet lab, which is exactly right — hypothesis generation is cheap and easy to get wrong, and validation remains the expensive, non-negotiable step no model removes. I'd also flag the source: this is OpenAI publishing a flattering case study, so treat it as a promising signal rather than proof of a general capability. But even discounted, a single documented instance of an AI unsticking a three-year problem is enough to make hypothesis-generation a serious research direction rather than a marketing line.